BMC Psychiatry

Table 1 Study measures and measurement points

From: Protocol for the ENCODE trial: evaluating a novel online depression intervention for persons with epilepsy

	MINI^a	PHQ-9^b	NDDIE^c	GAD-7^d	DASS-21^e	WSAS^f	Subjective usefulness of the program	INEP^g	Epilepsy symptom severity^h	Medication adherenceⁱ	Health-related quality of life^j	ESMS^k
T0 baseline	X	X	X	X	X	X			X	X	X	X
T1 (3 months post-baseline)		X	X	X	X	X	X^l	X^l	X	X	X	X
T2 (6 months post-baseline)		X	X	X	X	X	X	X^m	X	X	X
T3 (9 months post-baseline)		X	X	X	X	X	X^m		X	X	X

^aMINI Neuropsychiatric Interview
^bPatient Health Questionnaire
^cNeurological Disorders Depression Inventory for Epilepsy
^dGeneralized Anxiety Disorder questionnaire, 7 items
^eDepression and Anxiety Scales
^fWork and Social Adjustment Scale
^gInventory for the Assessment of Negative Effects of Psychotherapy
^hPESOS and Liverpool Seizure Severity Scale (LSSS)
ⁱRief Adherence Index (RAI)
^jQOLIE-10-P (Quality of Life Inventory in Epilepsy)
^kEpilepsy Self-Management Scale
^lOnly patients in the intervention group
^mOnly patients in the control group

Back to article page

ISSN: 1471-244X

Contact us

Submission enquiries: bmcpsychiatry@biomedcentral.com
General enquiries: ORSupport@springernature.com